Higher levels of TGFBIp are correlated with severity of COVID-19 symptoms

Higher levels of TGFBIp are correlated with severity of COVID-19 symptoms

Higher levels of TGFBIp are correlated with severity of COVID-19 symptoms

A new study found raised levels of transforming growth factor beta-induced protein (TGFBIp) in blood sampled from roughly 100 people hospitalized for COVID-19, and further found that elevated levels of both the normal and acetylated forms of TGFBIp correlated with the severity of disease symptoms in these patients.